PU WANG

Prof. PU WANG

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2011 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
PWPU WANG
PU WANG
JCJin-Bo Cai
Jin-Bo Cai
QOQi Ouyang
Qi Ouyang
JHJun-Yao He
Jun-Yao He
HSHui-Zhen Su
Hui-Zhen Su

1 May 2013 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
WZWeiyu Zhang
Weiyu Zhang
JHJin Huang
Jin Huang
XWXingde Wo
Xingde Wo
PWPU WANG
PU WANG

23 May 2013 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
JLJun Li
Jun Li
PWPU WANG
PU WANG
JHJun-Yao He
Jun-Yao He
JHJin Huang
Jin Huang
JTJun Tang
Jun Tang

1 May 2014 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
NWNeng-Qiang Wang
Neng-Qiang Wang
JSJing Sun
Jing Sun
JHJin Huang
Jin Huang
PWPU WANG
PU WANG
(R)-[3,5-bis(trifluoromethyl)phenyl] ethanol ((R)-BTPE) is a valuable chiral intermediate for the synthesis of antiemetic drug Aprepitant and Fosaprepitant. A Leifsonia xyli HS0904-derived carbonyl reductase (LXCAR), an effective biocatalyst for the asymmetric reduction of 3,5-bis(trifluoromethyl) acetophenone (BTAP) to (R)-BTPE, was overexpressed in Escherichia coli BL21 (DE3). Bioinformatics analysis indicated that the amino acid sequence of recombinant LXCAR showed 89 % similarity to short-chain dehydrogenase/reductase. E. coli recombinant carbonyl reductase crude extract showed a specific activity of 1.54 U/mg, which was 62 times higher than that of L. xyli HS0904 crude extract. By using error-prone polymerase chain reaction and site-directed mutagenesis, the engineered LXCAR demonstrated superior catalytic activity toward BTAP, and the obtained mutant LXCAR-S154Y exhibited nearly 13-fold, 5.4-fold, and 2.3-fold increase in k cat/K m value, k cat value, and specific activity toward BTAP, respectively, compared to the recombinant LXCAR. Additionally, the reduction of BTAP by whole cells of mutant LXCAR-S154Y afforded a best yield of 99.6 % for (R)-BTPE within 2 h at 200 mM BTAP, which was shortened by 28 and 2 h compared to those catalyzed by L. xyli HS0904 cells and recombinant E. coli cells expressing LXCAR, respectively. Moreover, a yield of 82.5 % for (R)-BTPE was achieved within 12 h at an increased BTAP concentration of up to 1,000 mM (256 g/l), representing a 1.9-fold increase over the recombinant LXCAR. Homology modeling and docking analysis revealed the molecular basis for the high catalytic activity of mutant LXCAR-S154Y toward BTAP. The results present here provide a promising alternative for economical and efficient production of chiral alcohols by engineered LXCAR.

13 March 2015 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Closed access
PDF file
JHJin Huang
Jin Huang
HDHongliang Dai
Hongliang Dai
RYRen Yan
Ren Yan
PWPU WANG
PU WANG

21 February 2020 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Closed access
PDF file
YHYushu He
Yushu He
QHQianyue Huang
Qianyue Huang
PWPU WANG
PU WANG